Last reviewed · How we verify
NCT06133660
Influence of Intravitreal Aqueous Tamponade on Lens Status and Ocular
trial testing pars plana vitrectomy in Aqueous Tamponade in 21 participants. Completed in 1 March 2023.
1 October 2022
Quick facts
| Lead sponsor | Bo Jia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 21 |
| Start date | 30 October 2020 |
| Primary completion | 1 October 2022 |
| Estimated completion | 1 March 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- pars plana vitrectomy
Conditions studied
- Aqueous Tamponade — all drugs for Aqueous Tamponade →
- Cataract — all drugs for Cataract →
Sponsor
Bo Jia
Who can join
Adults 16 to 65, any sex, with Aqueous Tamponade or Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To observe the effects of vitreous cavity Balanced salt solution (BSS) tamponade on the state of the lens and related parameters of the eye, and whether the changes of the above parameters are correlated with age, gender, diabetes or not, etc., so as to provide references for the diagnosis and treatment of related diseases and scientific research.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06133660
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of pars plana vitrectomy
Trials testing the same drug.
- NCT05367193 — 3D Visualization System for Vitreoretinal Diseases in Highly Myopic Eyes · NA · completed
- NCT06233500 — Macular Micro Vascular Changes Following Macular Hole Repair : Optical Coherence Tomography Angiography Study · NA · unknown
- NCT04774146 — Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy · unknown
- NCT04712786 — Refractive Changes Following Vitrectomy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06133660 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bo Jia
- Last refreshed: 15 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06133660.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing